L&G Healthcare Breakthrough UCITS ETF USD Accumulating ETF/  IE00BK5BC677  /

Fonds
NAV07/06/2024 Var.-0.1073 Type of yield Focus sugli investimenti Società d'investimento
11.4849USD -0.93% reinvestment Equity Worldwide LGIM Managers (EU) 

Investment strategy

The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices. Shares in this Share Class (the "Shares") are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the "Dealing Timetable" published on http://www.lgim.com.The Index is comprised of companies which are publically traded on various stock exchanges around the world that generate a proportion of their revenues from the healthcare technology industry. The industry is deemed to be comprised of the following nine subsectors: diagnostic, lab process automation, genomics, regenerative medicine, precision medicine, telehealth, data analytics, robotics and medical instruments. A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" (a measure of how actively its shares are traded on a daily basis).
 

Investment goal

The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
 

Dati master

Type of yield: reinvestment
Fondi Categoria: Equity
Region: Worldwide
Settore: ETF Stocks
Benchmark: ROBO Global® Healthcare Technology and Innovation Index
Business year start: 01/07
Ultima distribuzione: -
Banca depositaria: The Bank of New York Mellon SA/NV
Domicilio del fondo: Ireland
Permesso di distribuzione: Austria, Germany, Switzerland
Gestore del fondo: -
Volume del fondo: 71.42 mill.  USD
Data di lancio: 17/06/2019
Investment focus: -

Condizioni

Sovrapprezzo emissione: 0.00%
Tassa amministrativa massima: 0.49%
Investimento minimo: 1.00 USD
Deposit fees: -
Redemption charge: 0.00%
Prospetto semplificato: Download (Print version)
 

Società d'investimento

Funds company: LGIM Managers (EU)
Indirizzo: 2 Dublin Landings, 1-W-131, Dublin
Paese: Ireland
Internet: www.lgim.com/ie/
 

Attività

Stocks
 
99.85%
Cash
 
0.12%
Altri
 
0.03%

Paesi

United States of America
 
78.45%
Switzerland
 
5.47%
Netherlands
 
4.09%
Jersey
 
2.09%
Italy
 
1.96%
Germany
 
1.64%
Luxembourg
 
1.56%
Canada
 
1.27%
China
 
1.23%
United Kingdom
 
1.19%
Japan
 
0.90%
Cash
 
0.12%
Altri
 
0.03%

Filiali

Healthcare
 
95.97%
IT/Telecommunication
 
2.65%
Consumer goods
 
1.23%
Cash
 
0.12%
Altri
 
0.03%